Quantcast
Last updated on April 24, 2014 at 17:35 EDT

Latest Prismic Pharmaceuticals Inc. Stories

2013-12-03 08:33:43

SCOTTSDALE, Ariz., Dec. 3, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, commercial-stage pharmaceutical company focused on prescription Medical Foods, today announced the election of Francesco Granata, M.D., to its Board of Directors. Dr. Granata is currently Executive in Residence at Warburg Pincus, a leading private equity firm focused on growth investing. He is an accomplished healthcare executive with more than 35 years of experience in the...

2013-08-13 08:30:22

SCOTTSDALE, Ariz., Aug. 13, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., the Scottsdale, Arizona-based pharmaceutical company, today announced that it has secured another worldwide agreement. This time, the agreement covers inflammatory and painful conditions such as Diabetic Neuropathy and other Neuropathic disorders, as well as Osteo and Rheumatoid Arthritis and other pain-related conditions. Prismic signed the strategic partnership agreement with the Italian company...

2013-06-13 08:27:58

SCOTTSDALE, Ariz., June 13, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company, today announced that it has secured exclusive licensing rights to Palmitoylethanolamide (PEA), including the micronized and ultra-micronized forms, a novel non-steroidal, kidney-friendly anti-inflammatory and anti-fibrotic agent with a well-documented safety profile in humans. Commenting on securing the rights to this important new agent, Prismic's Chief...

2013-04-10 08:32:55

SCOTTSDALE, Ariz., April 10, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, emerging pharmaceutical company specializing in prescription Medical Foods, today announced the appointment of a number of International Advisors to its International Commercial Advisory Board. Board members will act as a "sounding board" for Prismic's senior management and Board of Directors in terms of providing input and opinions regarding pharmaceutical/healthcare industry...

2013-02-12 08:32:08

SCOTTSDALE, Ariz., February 12, 2013 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based pharmaceutical company focused on prescription Medical Foods, today announced that Danilo Casadei Massari, the founder of CM&D Pharma recently acquired by Nestle, has joined Prismic's Management Team and Board of Directors. Casadei Massari, who has an outstanding reputation as a successful healthcare entrepreneur, becomes President Europe with additional responsibility...

2012-02-07 07:17:00

SCOTTSDALE, Ariz., Feb. 7, 2012 /PRNewswire/ -- Prismic Pharmaceuticals, Inc., a Scottsdale, Arizona-based, emerging pharmaceutical company, today announced that it has completed the acquisition of the assets of Scarista Limited. In particular, Prismic has acquired Scarista's exclusive license from Amarin Neuroscience Limited, a wholly owned subsidiary of Amarin Corporation, to develop, market, and out-license products based on a portfolio of issued U.S. and foreign composition and use...